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Summary
Epithelial cells possess apical-basolateral polarity and form
tight junctions (TJs) at the apical-lateral border, separating
apical and basolateral membrane domains. The PAR3-
aPKC-PAR6 complex plays a central role in TJ formation
and apical domain development during tissue morphogen-
esis [1–4]. Inactivation and overactivation of aPKC kinase
activity disrupts membrane polarity [5–8]. The mechanism
that suppresses active aPKC is unknown. KIBRA, an
upstream regulator of the Hippo pathway, regulates tissue
size in Drosophila [9–11] and can bind to aPKC [12, 13].
However, the relationship between KIBRA and the PAR3-
aPKC-PAR6 complex remains unknown. We report that
KIBRAbinds to the PAR3-aPKC-PAR6 complex and localizes
at TJs and apical domains in epithelial tissues and cells. The
knockdownof KIBRA causes expansion of the apical domain
inMDCK three-dimensional cysts and suppresses the forma-
tion of apical-containing vacuoles through enhanced de
novo apical exocytosis. These phenotypes are restored by
inhibition of aPKC. In addition, KIBRA directly inhibits the
kinase activity of aPKC in vitro. These results strongly
support the notion that KIBRA regulates epithelial cell
polarity by suppressing apical exocytosis through direct
inhibition of aPKC kinase activity in the PAR3-aPKC-PAR6
complex.
Results and Discussion
KIBRA Interacts with the PAR3-aPKC-PAR6 Complex
and Localizes at the Apical Domain in Mammalian
Epithelial Cells
Previous studies on the direct interaction of KIBRA to aPKC
[12, 13] suggest the involvement of KIBRA on epithelial cell
polarity. To evaluate this possibility, we first examined its inter-
action with the PAR-aPKC complex. Immunoprecipitation
experiments on ectopic proteins expressed in HEK293T cells
(Figure 1A) as well as endogenous proteins in MDCK epithelial
cells using an antibody raised against KIBRA (Figure 1B; Fig-
ure S1A available online) revealed that aPKC, PAR6b, and*Correspondence: ohnos@med.yokohama-cu.ac.jp (S.O.), acchida@mail.
ecc.u-tokyo.ac.jp (K.C.)PAR3 coimmunoprecipitates with KIBRA. These results
suggest that KIBRA can tightly associate with the PAR3-
aPKC-PAR6 complex in epithelial cells.
The PAR3-aPKC-PAR6 complex localizes to TJs and the
aPKC-PAR6 complex localizes to both TJ and apical domains
in a variety of polarized epithelial cells and tissues including
MDCK cells [5, 14–16]. Immunostaining of polarized MDCK
monolayers revealed that KIBRA localizes to the cytoplasm
and apical cell-cell junctions (Figure 1C; Figure S1B). In
MDCK cysts, the KIBRA staining clearly localizes at the apical
domain and cell-cell junctions (Figure 1D). In the mouse
kidney, KIBRA staining localizes at the apical cell-cell junc-
tions of the distal tubular epithelium (Figure 1E; Figure S1C).
Thus, the localization of KIBRA in polarized epithelial cells is
very similar to that of aPKC, supporting the notion that KIBRA
is involved in epithelial cell polarization with the PAR3-aPKC-
PAR6 complex.
KIBRA Suppresses Apical Domain Expansion during Cyst
Formation
To evaluate the role of KIBRA on epithelial cell polarity, we
established two independent MDCK cell clones with dimin-
ished KIBRA expression (KIBRA-kd1 and KIBRA-kd2). The
expression of KIBRA was decreased to 10% (Figure 2A) and
the apical and junctional staining of KIBRA was diminished in
KIBRA-kd clones in both 2D and 3D cultures (Figures S1D
and S1E), whereas the expression of other polarity proteins
such as aPKC, PAR3, PAR6b, Lgl2, and PAR1b were not
affected (Figure 2A).
We first assessed the involvement of KIBRA in the morpho-
genesis of cysts in a collagen gel. Comparedwith control cysts
with a single and flat-surface apical lumen [7, 8], the KIBRA-
kd1 clone generated cysts of peculiar morphology, where
the apical domain of the cells in the cysts was expanded
(Figures 2B and 2C). Another clone with a different target
sequence, KIBRA-kd2, also generated cysts with the
expanded apical domain (Figures 2B and 2C). Consistently,
the expression of an apical marker protein, gp135/podoca-
lyxin, was enhanced in KIBRA-kd clones (Figure 2A). These
results suggest a role for KIBRA in apical domain development
of epithelial cells.
Recent studies in Drosophila revealed that Kibra acts as an
activator of the Hippo pathway via interaction with the
upstream regulators Merlin and Expanded through the
N-terminal WW domains [9–11]. The Hippo pathway has previ-
ously been implicated in epithelial cell polarity control; epithe-
lial cells of Drosophila Hippo pathway mutants display apical
hypertrophy resulting from increased activation of the tran-
scriptional coactivator protein Yorkie [17, 18]. These results
suggest that KIBRA suppress apical development by acti-
vating the Hippo pathway. To evaluate this, we first confirmed
that active mouse YAP1 (YAP1 S112A), whose Lats1/2-phos-
phorylation site was substituted to alanine [19], induces apical
expansion in MDCK cysts (Figures S2A and S2B). This
suggests that YAP is involved in apical domain expansion
not only in Drosophila but also in mammalian epithelial cells.
We next examined the involvement of YAP in KIBRA
knockdown-induced apical expansion via dominant-negative
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Figure 1. KIBRA Interacts and Colocalizes with
the PAR-aPKC Complex at the Apical Junctions
of Polarized Epithelial Cells
(A) Coimmunoprecipitation of the KIBRA and
PAR-aPKC complexes in HEK293T cells.
KIBRA-Flag was coexpressed with T7-aPKCl,
T7-PAR6b, or T7-PAR3 in HEK293T cells and
precipitated with Flag antibody (IP), then sub-
jected to immunoblotting with antibodies indi-
cated. Note that endogenous aPKCl and
PAR6b coprecipitated with KIBRA-Flag.
(B) Coimmunoprecipitation of endogenous
KIBRA and PAR-aPKC complex in MDCK cells.
Coomassie brilliant blue (CBB) staining of the
IgG heavy chain is shown on the bottom.
(C) Subcellular localization of KIBRA in MDCK
monolayers. The cells were fixed and stained
for KIBRA (green), ZO-1 (red), and F-actin (blue).
The signal specificity of KIBRA antibody was
confirmed by antigen blocking (Figure S1B).
(D) Subcellular localization of KIBRA in MDCK
cysts. MDCK cysts were cultured in type I
collagen gel for 4 days, then stained for KIBRA
(green) and F-actin (red).
(E) Subcellular localization of KIBRA in themouse
kidney. Mouse kidneys were stained for KIBRA
(green), ZO-1 (red), and DAPI (blue). DT, distal
tubule; PT, proximal tubule. The signal specificity
of KIBRA antibody was confirmed by antigen
blocking (Figure S1C).
Scale bars represent 10 mm (C–E). See also
Figure S1.
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706YAP1 (dnYAP1), whose transcriptional activation domain is
replaced to transcriptional repression domain of Drosophila
Engrailed [19]. Consistent with the predicted function of
YAP1 in cell growth, dnYAP1-expressing control clonefrequently formed smaller cysts and
cell aggregates when embedded in
collagen gels. However, dnYAP1 did
not completely rescue the apical expan-
sion phenotype in KIBRA-kd cysts
(Figures S2A and S2B). Moreover,
significant effects on the phosphoryla-
tion of YAP1 (Figure S2C) or the localiza-
tion of YAP1 in cysts (Figure S2D) were
not observed in KIBRA-kd clones.
These results suggest that the apical
expansion in KIBRA-kd cysts might
involve unknown mechanisms in addi-
tion to YAP.
KIBRA Is Required for Formation
of the Vacuolar Apical Compartment
To gain insight into the novel mecha-
nisms that regulate epithelial polarity,
we examined the phenotype of KIBRA-
kd clones in calcium switch (CS) and
calcium depletion assays. Depletion of
KIBRA did not show any significant
defect in the recruitment of the TJ
marker ZO-1 to the apical junction or
transepithelial electrical resistance
(TER) after a CS (Figures S3A and
S3B). These results show that KIBRA is
not critically involved in cell-cellcontact-dependent junction formation. Previous studies have
established that in the absence of cell-cell contact, MDCK
cells form a structure called the vacuolar apical compartment
(VAC), where newly synthesized or endocytosed apical
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Figure 2. Knockdown of KIBRA Causes Apical
Domain Expansion in MDCK Cysts
(A) Lysates derived from nonsilencing and two
different KIBRA-shRNA-expressing MDCK cell
clones were subjected to immunoblotting with
the antibodies indicated. Blotting for glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) was
used as a loading control.
(B) Nonsilencing and KIBRA-kd clones were
cultured in type I collagen gel for 5 days then
stained for aPKC (green), E-cadherin (red), and
ZO-1 (blue). Scale bars represent 10 mm.
(C) Cysts containing normal, multiple lumens, or
apical expanded lumen (apical expansion) were
counted in nonsilencing and KIBRA-kd clones.
Amorphous-shaped cysts were categorized as
having no lumen. More than 100 cysts were
counted and categorized, and the percentage of
the cyst in each category was calculated. Values
represent the mean 6 SD of three independent
experiments. *p < 0.001 versus nonsilencing
clone by Student’s t test. See also Figure S2.
KIBRA Inhibits aPKC and Apical Exocytosis
707proteins accumulate [20, 21]. Genetic manipulation of the
components of the PAR3-aPKC-PAR6 complex or Lgl affects
VAC formation [7, 8]. Calcium depletion induced the appear-
ance of VACs, aggregates of gp135 that costained with
F-actin, in 50% of control cells as reported previously [7]. In
contrast, VAC formation was almost completely suppressed
in KIBRA-kd clones (Figures 3A and 3B; Figures S3C and
S3D), similarly to Lgl1/2 knockdown [7]. These results indicate
that KIBRA is required for the formation of the VAC under de-
polarized conditions, suggesting that KIBRA affects some
step(s) of apical protein trafficking.
KIBRA Suppresses Exocytosis of Apical Membrane
The knockdown of Lgl1/2 suppresses VAC formation in depo-
larizedMDCK cells as observed in KIBRA-kd clones [7]. Lgl-kd
cells cultured in 2D showed resistance to apical domain inter-
nalization when the apical-free surface was overlaid withcollagen gels (Figure S3E) [7]. However,
KIBRA-kd cells showed internalization
of apical proteins and formation of inter-
cellular lumens in response to collagen
overlay comparable to control clone,
making a clear contrast to Lgl-kd cells
(Figure S3E). These results suggest
that KIBRA and Lgl regulate apical
protein transport in a different manner.
KIBRA may suppress apical exocy-
tosis to avoid apical expansion. To
directly evaluate the role of KIBRA on
the exocytosis of apical proteins, we
traced the newly synthesized fusion
protein of GFP and p75 neurotrophin
receptor, a non-raft apical protein
marker [22]. A tetracycline (Tet)-induc-
ible (Tet-Off) p75-GFP adenovirus
expression vector was used to induce
p75-GFP expression after the cells
were fully depolarized (Figure 3C).
In the control cells with VACs, only
a small proportion of p75-GFP was exo-
cytosed to the cell surface. In KIBRA-depleted cells, which failed to form VACs, enhanced surface
expression of p75-GFP was evident (Figures 3D and 3E; Fig-
ure S3F). These results strongly support the notion that exocy-
tosis of newly synthesized p75 is enhanced in KIBRA-kd
clones, implicating the role of KIBRA in the suppression of
apical protein exocytosis.
KIBRA Inhibits the Kinase Activity of aPKC Required
for Apical Domain Development
KIBRA binds directly to the kinase domain of aPKC [12, 13].
The sequence of the aPKC binding region in KIBRA (KIBRA-
aBR) is highly conserved among species, from Drosophila to
humans, and contains a sequence similar to the pseudosub-
strate (PS) of aPKC, suggesting a role in the regulation of
aPKC kinase activity (Figure 4A). We purified Flag-tagged
aPKC, KIBRA, and DC-KIBRA, which lacks the aPKC binding
region (Figure 4A) [13], from HEK293T cells (Figure S4A) and
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Figure 3. Knockdown of KIBRA Suppresses VAC Formation through Enhancement of Apical Exocytosis
(A) Confluent monolayers were incubated with low calcium (LC) medium for 20 hr, fixed, and stained for gp135, F-actin, and ZO-1. Projected views of optical
sections are shown. Arrowheads indicate where VACs localized. The images for KIBRA-kd2 are shown in Figure S3D.
(B) Quantification of cells with aggregated gp135 staining. The percentage of total cells is shown. Values are mean6 SD of three independent experiments.
*p < 0.05 versus nonsilencing clone by Student’s t test.
(C) Schematic of an experiment to evaluate apical exocytosis.
(D) Representative images of confluent monolayers of stable clones treated as in (C). A projected view of apical to basal sections is shown. Arrowheads
indicate where VAC was localized. The images for KIBRA-kd2 are shown in Figure S3F.
(E) Quantification of the results in (D). Data represent the results of 42 cells for nonsilencing, 42 cells for KIBRA-kd1, and 63 cells for KIBRA-kd2 clones from
three independent experiments.
*p < 0.00001 by the two-tailed Mann-Whitney U-test. Bar indicates the median. Scale bars indicate 10 mm (A and D). See also Figure S3.
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708performed in vitro kinase assays. The purified KIBRA inhibited
the activity of aPKC in a dose-dependent manner (Figure 4B;
Table S1) in the presence of excessive amounts of the
substrate, myelin basic protein (MBP; approximately 10 mM).
However, this inhibition was not observed for DC-KIBRA (Fig-
ure 4B; Table S1). A Lineweaver-Burk plot demonstrated that
KIBRA inhibited aPKC in a competitive manner (Figure 4C;
Table S2) and a Dixon plot showed that the Ki value was
2–3 nM (Figure 4D). Furthermore, purified GST-tagged
KIBRA-aBR (Figure S4A) also inhibited the kinase activity of
aPKC in a dose-dependent manner and its inhibition was
competitive (Figures S4B and S4C; Tables S1 and S2). These
results clearly establish that KIBRA directly binds to aPKC
and inhibits its kinase activity in a cell-free system.
Next, we investigated whether the interaction between
aPKC and KIBRA is required for apical development. The
apical expansion phenotype in the KIBRA-kd1 clone was
almost completely suppressed by the re-expression of
EGFP-KIBRA, and the re-expression of DC-KIBRA did not
completely rescue the phenotype (Figures 4E–4G). These
results suggest that the C-terminal region of KIBRA is requiredfor suppression of apical development. We also examined
whether KIBRA-aBR was sufficient for aPKC inhibition to
suppress apical development by overexpressing tRFP-tagged
KIBRA-aBR (tRFP-KIBRA-aBR) in wild-type MDCK cells. As
expected, the overexpression of tRFP-KIBRA-aBR increased
the occurrence of VAC formation, which is similar to aPKC inhi-
bition (Figures S4D and S4G). We confirmed the interaction
between endogenous aPKC and tRFP-KIBRA-aBR in the cyto-
plasm (data not shown), although tRFP-KIBRA-aBR exhibited
relatively strong nuclear localization by immunofluorescence
(Figure S4D). These results are consistent with the notion
that KIBRA suppresses apical domain development by directly
inhibiting the kinase activity of aPKC.
To obtain further evidence supporting the involvement of the
interaction between KIBRA and aPKC, we next examined
whether the phenotypes observed in KIBRA-kd clones were
rescued by inhibition of the kinase activity of aPKC. The
KIBRA-kd clones treated with aPKC inhibitor exhibited
increased VAC formation in a dose-dependent manner (Figures
S4E and S4H). Furthermore, apical expansion phenotype in
KIBRA-kd cysts were partially rescued by treatment with
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Figure 4. KIBRA Suppresses Apical Expansion through Inhibition of aPKC Kinase Activity
(A) Schematic diagram for KIBRA and DC-KIBRA and a sequence alignment of the aPKC binding region (aBR) of KIBRA. The sequence of aPKCz-PS is
shown at the top. Hs, human; Mm,mouse; Rn, rat; Gg, chicken; Xl, Xenopus; Dr, zebrafish; Dm,Drosophila. Asterisk indicates the serine residues phosphor-
ylated by aPKCz in vitro [12].
(B) In vitro kinase assay with purified PKCz and MBP as a substrate in the presence of KIBRA-Flag (gray) or DC-KIBRA (white). Relative activities of PKCz if
the activity of PKCz in the absence of KIBRA-Flag or DC-KIBRA-Flag was designated as 1 are shown. *p < 0.05, **p < 0.005, ***p < 0.0005.
(C) Double reciprocal plot of initial velocity (pmol/min) of PKCz versus substrate concentration (mg/ml) in the absence of KIBRA (0 nM, filled diamond) andwith
5 (square), 10 (circle), and 20 (filled circle) nM KIBRA at various concentrations of MBP (100, 133, 200, and 400 mg/ml) yielded the Lineweaver-Burk plot. Data
from three independent experiments were plotted.
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71020mMaPKC inhibitor,which did not affect normal cyst formation
in control clone (Figures S4F and S4I). These results strongly
support the notion that the increased apical domain develop-
ment in KIBRA-kd clones were caused by upregulation of
aPKC kinase activity.
KIBRA Is a Negative Regulator of aPKC during Apical
Development
Previous studies have demonstrated that KIBRA directly binds
to and is phosphorylated by aPKC, suggesting that KIBRA is
a scaffold protein or a phosphorylation target that mediates
aPKC activity to the downstream events [12, 23]. However,
the knockdown of KIBRA did not affect TJ formation during
cell-cell contact-dependent polarization (Figures S3A and
S3B), showing a clear contrast to the cells in which aPKC
activitywas inhibited [5, 24]. Rather, KIBRAknockdownpheno-
type shows apical expansion in cysts (Figure 2) and increased
apicalexocytosis (Figure3), suggesting thatKIBRAknockdown
causes enhanced aPKC activity, which is required for apical
domain development [7, 8, 25]. Consistently, the abnormal
phenotypes of KIBRA-kd clones were substantially reverted
by inhibiting aPKC activity (Figure S4). Furthermore, KIBRA
exhibitedcompetitive inhibitory activity onaPKCkinaseactivity
in vitro through its aPKCbinding region.Wealso confirmed that
the aBR domain is sufficient and required for KIBRA activity to
regulate apical domain development (Figure 4). These observa-
tions support thenotion thatKIBRAacts as anegative regulator
of aPKC activity in apical domain development.
The apical expansion in MDCK cysts that was observed for
KIBRA-kd clones were similar to that observed for cells over-
expressing Crumbs3, which localizes to the apical domain
and cooperates with the PAR complex for apical domain
development [26–29]. In Drosophila, Crumbs phosphorylation
by aPKC has been shown to be crucial for its function [30].
Therefore, KIBRA may inhibit apical domain development by
inhibiting Crumbs3 phosphorylation through aPKC. However,
we observed that overexpression of human Crumbs3 T89/
92A, with two threonine residues corresponding to aPKC
phosphorylation sites inDrosophila altered to alanine residues
[30], did not suppress the apical expansion phenotype in
KIBRA-kd clones (data not shown). This suggests the pres-
ence of additional unknown aPKC target(s) inhibited by KIBRA
during apical development. Recent studies suggest that aPKC
activity is required for mediating exocyst-dependent apical
vesicle docking to the PAR3-localizing site [8, 25]. Another
study suggested that KIBRA interacts with the exocyst
complex during directional migration of podocytes [31]. In
this work, we demonstrated that KIBRA knockdown upregu-
lated apical protein exocytosis (Figures 3C–3E). Taken
together, KIBRA may suppress apical vesicle docking to the
PAR3-localizing site through inhibition of aPKC kinase activity.
Conclusion
In this study, we provided evidence indicating that KIBRA
negatively regulates epithelial cell polarity by suppressing(D) Dixon plot of the MBP phosphorylation by aPKCz in the presence of KIBRA
diamond) of MBP, respectively, intersected at a point beyond the vertical axis.
axis yielded the value of Ki. Each data point demonstrates the results of three
(E) Lysates derived from rescue clones were subjected to immunoblotting with
genase (GAPDH) was used as a loading control.
(F) Rescue clones were cultured in type I collagen gel for 5 days, then stained
(G) More than 100 cysts were counted and categorized, and the percentage of t
three independent experiments. *p < 0.05 by one way-ANOVA, Turkey’s test. SaPKC kinase activity in the PAR-aPKC polarity complex
through its short C-terminal aPKC binding sequence. Our
results further indicate that this inhibitory effect of KIBRA on
aPKC mediates suppression of apical exocytosis, a process
implicated in the development of the apical domain and hence
epithelial cell polarity.
Experimental Procedures
Cell Culture and Transfection
MDCK and HEK293T cells were cultured in DMEM supplemented with 10%
FBS and 100 U/ml penicillin and streptomycin (GIBCO-BRL) at 37C/5%
CO2. Cells were transfected with Lipofectamine 2000 (Invitrogen) or
Nucleofector (Amaxa) with appropriate plasmids. KIBRA knockdown MDCK
cell clones were established by transfection with pSUPER-puro encoding
KIBRA shRNA sequences (50-GGTACAACCTCCTAAGCTA-30 for KIBRA-kd1
and 50-GGTTGGAGATTACTTCATA-30 for KIBRA-kd2) and selection with
2 mg/ml puromycin. Control clones were established similarly with a nonsi-
lencing sequence (50-CAGTCGCGTTTGCGACTGG-30). The mLgl1/2 double-
knockdown MDCK clone (24-15) was established previously [7]. Rescue
clones were established by transfection with the RNAi-resistant mouse
homolog of KIBRA. The pEGFP-C2, pEGFP-KIBRA, or pEGFP-DC-KIBRA
vectors were transfected into KIBRA-kd1 clone and selected with 800 mg/ml
G418. The control rescue clone was established similarly by transfection
and selection with the pEGFP-C2 vector and nonsilencing control clones.
Cyst Formation
MDCK cell cyst formation was performed as described previously [7]. Cysts
were fixed with 2% PFA/PBS for 30 min, permeabilized with 0.5% Triton
X-100/PBS for 30 min at room temperature, and immunostained as previ-
ously described [32].
Evaluation of the Exocytosis of Newly Synthesized p75-GFP
to the Cell Surface
Confluentmonolayers of stable cloneswerewashed twicewithPBScontain-
ing 0.02% EDTA and then incubated in LC medium for 2 hr. Cells were then
incubated with LC medium containing 2.5 3 107 pfu/ml of Tet-inducible
p75-GFP adenovirus expression vector for 2 hr. After infection, cells were
incubated in LCmediumwith 20 ng/ml doxycycline formore than 20 hr. Cells
were washed twice with PBS and then incubated in LC medium for a further
8 hr to allow for the expression of p75-GFP. Cells were fixed with 0.2% PFA/
PBS for 15min at room temperature andblockedwith 10%calf serum inPBS
for 30 min at room temperature. Surface p75-GFP was then labeled with
mouseanti-NGFRmonoclonal antibody (Chemicon, 8211),which recognizes
the ectodomain of human p75 [33]. After surface labeling, cells were refixed
with 4% PFA/PBS for 15 min at room temperature, permeabilized with 0.5%
Triton X-100/PBS for 10 min at room temperature, and reblocked with 10%
calf serum in PBS. To enhance the signal intensity of GFP, cells were incu-
bated with chicken anti-EGFP antibody (Aves Labs), which resulted in the
labeling of total p75-GFP. Samples were then incubated with Alexa
488-conjugated anti-chicken IgG and Alexa 555-conjugated anti-mouse
IgG antibodies, as well as Alexa 647-conjugated phalloidin.
Toquantify the rateof surface incorporationofnewlysynthesizedp75-GFP,
cells were randomly selected from samples, and the average signal intensity
ofsurfacep75-GFP(Alexa555)andthatof totalp75-GFP(GFP)wasmeasured
with ImageJ software. The average score of the resulting ratio (surface p75/
total p75) fromnonsilencing control cellswasdesignated as 1 for each exper-
iment, and the relative exocytosis rate was calculated for all selected cells.
In Vitro Kinase Assays
PKC activity wasmeasured in vitro by a standard vesicle assay with MBP as
a substrate, as described previously [34]. The incorporation of 32P withMBP
was determined by Cerenkov counting. The values for control reactions. Two different straight lines with 100 mg/ml (gray circle) or 400 mg/ml (black
A perpendicular line dropped from the point of intersection on the horizontal
independent experiments.
the antibodies indicated. Blotting for glyceraldehyde 3-phosphate dehydro-
for GFP (green), F-actin (red), and ZO-1 (blue). Scale bar represents 10 mm.
he cyst in each category was calculated. Values represent the mean6 SD of
ee also Figure S4 and Tables S1 and S2.
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711lacking the substrate were subtracted as blanks. Phosphorylation efficiency
(pmol/min) was calculated by comparing the obtained count to Cerenkov
counting for 10 pmol of ATP mixture.
Supplemental Information
Supplemental Information includes Supplemental Experimental Proce-
dures, four figures, and two tables and can be found with this article online
at doi:10.1016/j.cub.2011.03.029.
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